Risk of tuberculosis infection in anti-TNF-α biological therapy: From bench to bedside
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy
Reference61 articles.
1. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection;Roach;J Immunol,2002
2. Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans;Bruns;J Clin Invest,2009
3. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly
4. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry;Tubach;Arthritis Rheum,2009
5. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America;Taylor;MMWR Recomm Rep,2005
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The mechanism of Gejie Zhilao Pill in treating tuberculosis based on network pharmacology and molecular docking verification;Frontiers in Cellular and Infection Microbiology;2024-07-02
2. Mycobacterium tuberculosis Ankle Arthritis and Subsequent Immune-Reconstitution Inflammatory Syndrome;The American Journal of Medicine;2024-07
3. Icanbelimod (CBP-307), a next-generation Sphingosine-1-phosphate receptor modulator, in healthy men: pharmacokinetics, pharmacodynamics, safety, and tolerability in a randomized trial in Australia;Frontiers in Immunology;2024-06-17
4. The risk of tuberculosis infection in Saudi patients receiving adalimumab, etanercept, and tocilizumab therapy;Journal of Infection and Public Health;2024-06
5. Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis;RMD Open;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3